JOHNSON & JOHNSON (JNJ) Business News Aug. 28, 2026, 13:52 UTC Clinical trial NCT04929210: primary completion date: 2026-08-04 → 2027-04-01. Full text
Register to leave comments News bot Aug. 28, 2026, 2:05 p.m. 📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical